12 June 2018 Elicitation with SHELF training, 3-6 September 2018 www.tonyohagan.co.uk/shelf/CourseSep18.html
10 June 2018 New paper by John Stevens accepted for publication in PharmacoEconomics, "Using evidence from randomised controlled trials in economic models: What information is relevant and is there a minimum amount of sample data required to make decisions?"
3-6 June 2018 Kate Ren presenting "Evidence synthesis with limited studies: incorporating genuine prior information about between-study heterogeneity" at 2018 PSI Annual Conference in Amsterdam
2 April 2018 Proposal for oral presentation accepted at HTAi 2018 Annual Meeting Vancouver, Canada: Evidence synthesis with limited studies Shijie Ren, Jean Hamilton, Jeremy Oakley, John Stevens
29 March 2018 New paper published online in Medical Decision Making by Shilie Ren, Jeremy Oakley and John Stevens on incorporating genuine prior information about between-study heterogeneity in random effects pairwise and network meta-analyses.
1 March 2018 Advanced workshop proposal accepted for presentation at the ISPOR 23rd Annual International Meeting to be held May 19-23, 2018 at the Baltimore Convention Center in Baltimore, MD: ADJUSTING FOR BETWEEN-TRIAL DIFFERENCES IN THE SCHEDULE OF ASSESSMENT FOR DISEASE PROGRESSION IN IMMUNO-ONCOLOGY AND ITS IMPACT ON INDIRECT TREATMENT COMPARISONS. Venediktos Kapetanakis, Agnes Benedict, Michael Schlichting, John Stevens
1 March 2018 Abstract for podium presentation accepted for presentation at the ISPOR 23rd Annual International Meeting to be held May 19-23, 2018 at the Baltimore Convention Center in Baltimore, MD: ASSESSMENT-TIME BIAS: STATISTICAL APPROACHES TO ADJUSTING FOR BETWEEN-TRIAL DIFFERENCES IN THE SCHEDULE OF ASSESSMENT FOR DISEASE PROGRESSION IN IMMUNO-ONCOLOGY TRIALS. Kapetanakis V, Schlichting M, Stevens JW, Prawitz T, Kearney M, Phatak H, Benedict A, Bharmal M
17 December 2017 New paper published online in Research Synthesis Methods by John Stevens, Chrissie Fletcher, Gerry Downey and Anthea Sutton giving a review of methods for comparing treatments evaluated in studies that form disconnected networks of evidence.